Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - Tongli Pharmaceuticals (USA), Inc. | v353189_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Tongli Pharmaceuticals (USA), Inc. | v353189_ex31-2.htm |
| EX-32.1 - EXHIBIT 32.1 - Tongli Pharmaceuticals (USA), Inc. | v353189_ex32-1.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Tongli Pharmaceuticals (USA), Inc. | Financial_Report.xls |
| 10-Q - FORM 10-Q - Tongli Pharmaceuticals (USA), Inc. | v353189_10q.htm |
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
SECTION 906 CERTIFICATION
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Tongli Pharmaceuticals (USA), Inc. (the "Company”) on Form 10-Q for the three months ended June 30, 2013 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Li Li, certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
Date: August 19, 2013
/s/ Li Li
Li Li
| Chief Financial Officer |